Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy

被引:18
作者
Pan, JW
Coyle, PK
Bashir, K
Whitaker, JN
Krupp, LB
Hetherington, HP
机构
[1] SUNY Stony Brook, Brookhaven Natl Lab, Dept Med, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA
[3] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA
关键词
magnetic resonance spectroscopy; metabolism; multiple sclerosis; N-acetyl aspartate; primary progressive;
D O I
10.1191/1352458502ms802oa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We used quantitative magnetic resonance (MR) spectroscopic imaging with T1-based image segmentation to evaluate the subtypes of multiple sclerosis (MS) (eight patients each group of relapsing-remitting [RR], secondary progressive [SP] and primary progressive [PP]). There was no significant difference in age between the PP group with the RP, SP or control group. We found that the metabolite ratio of choline/NA from the periventricular white matter region was not significantly different between the RR and SP groups. Using an ANOVA, the ratios of periventricular choline/NA or creatine/NA of these combined groups were significantly higher than the PP and control groups. Quantification of these data suggest that the major cause of the elevation of these parameters is due to an increase in choline and creatine in the RR group while NA is decreased in the SP group. Thus, early PP disease appears to be relatively intact with respect to neuronal loss.
引用
收藏
页码:200 / 206
页数:7
相关论文
共 32 条
[1]  
BASHIR K, NEUROLOGY, V53, P765
[2]   In vitro expression of N-acetyl aspartate by oligodendrocytes:: Implications for proton magnetic resonance spectroscopy signal in vivo [J].
Bhakoo, KK ;
Pearce, D .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :254-262
[3]  
CHU WJ, 1998, INT SOC MAGN RES MED, P543
[4]   N-acetyl aspartate:: A marker for neuronal loss or mitochondrial dysfunction [J].
Clark, JB .
DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (4-5) :271-276
[5]  
Cucurella MG, 2000, NMR BIOMED, V13, P57, DOI 10.1002/(SICI)1099-1492(200004)13:2<57::AID-NBM609>3.0.CO
[6]  
2-5
[7]   Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? [J].
Davie, CA ;
Silver, NC ;
Barker, GJ ;
Tofts, PS ;
Thompson, AJ ;
McDonald, WI ;
Miller, DW .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (06) :710-715
[8]   Immunological profile of patients with primary progressive multiple sclerosis -: Expression of adhesion molecules [J].
Durán, I ;
Martínez-Cáceres, EM ;
Río, J ;
Barberá, N ;
Marzo, ME ;
Montalban, X .
BRAIN, 1999, 122 :2297-2307
[9]  
FISHER JS, 1999, BRAIN 5, V122, P871
[10]   Correlates of executive function in multiple sclerosis: The use of magnetic resonance spectroscopy as an index of focal pathology [J].
Foong, J ;
Rozewicz, L ;
Davie, CA ;
Thompson, AJ ;
Miller, DH ;
Ron, MA .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (01) :45-50